
|Articles|June 26, 2008
HIV drug Aptivus gains new indication approval for kids
Boehringer Ingelheim's Aptivus can now be used to treat HIV-infected pediatric patients.
Advertisement
Pediatric patients between two and 18 years of age who are infected with HIV have a new treatment available to them. It’s Boehringer Ingelheim Pharmaceuticals’
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Study Confirms “Pandemic Fatigue” Occurred Due to Social Restrictions, Compliance to Preventative Measures
2
FDA Approves Aflibercept Injection for Macular Edema Following Retinal Vein Occlusion
3
FDA Approves Denosumab-Desu as Biosimilar to Prolia, Xgeva
4
CDC Updates Webpage, Saying No Evidence Supports “Vaccines Do Not Cause Autism” Claims
5












































































































































